Frontier Botanics is building one of Africa’s lowest-cost, highest-quality medicinal cannabis platforms. Already operational and GACP-certified, we are positioned at the forefront of Europe’s fastest-growing pharmaceutical market.


Frontier Botanics is building one of Africa’s lowest-cost, highest-quality medicinal cannabis platforms. Already operational and GACP-certified, we are positioned at the forefront of Europe’s fastest-growing pharmaceutical market.

CEO & Founder
“At Frontier Botanics, we are building a trusted, sustainable future for high-quality medical cannabis.”
A unique combination of ideal growing conditions, progressive regulation, and cost-efficient production makes Lesotho a prime location for scalable medical cannabis cultivation.
Located in the heart of Lesotho, our cultivation facility benefits from an ideal combination of high altitude, clean air, and abundant sunlight—creating optimal conditions for producing premium, pharmaceutical-grade medical cannabis. The region’s stable climate allows for consistent, year-round growing, supporting both quality control and scalable output.
Built to meet strict international standards, the facility integrates modern agricultural technology with rigorous compliance protocols. From cultivation through to processing, every stage is carefully managed to ensure product consistency, traceability, and alignment with global medical and export regulations.



![shutterstock_1393829357 [Converted] Kingdom of Lesotho](https://frontierbotanics.com/wp-content/uploads/2019/06/shutterstock_1393829357-Converted-e1561486258182.png)

The global medicinal cannabis market is undergoing a structural shift. Regulatory reform across Europe, combined with growing clinical evidence and patient demand, is creating a multi-billion-pound opportunity that is still in its earliest stages.
Positioned within a rapidly expanding global medical cannabis industry with strong long-term demand.
Established cultivation in Lesotho allows for cost-efficient, large-scale production.
Operating within fully legal, compliant frameworks across both African and UK markets.
Early positioning in an evolving sector with increasing medical adoption and limited established competition.
A simple, transparent process designed to guide you from initial interest through to securing your investment with confidence.

Submit your details to receive the investor pack and key information about the opportunity.
Assess financials, projections, and operational plans to understand the growth strategy.
Engage directly with the Frontier Botanics team to ask questions and gain deeper insight.
Complete the required agreements and formally participate in the funding round.
Flexible opportunities designed to align with your investment goals while supporting scalable growth and long-term value creation.
Clear answers to common questions about our operations, compliance, and investment opportunity.
What question or topic would you like assistance with today?
Yes. Medical cannabis has been legal in the UK since November 2018 following changes introduced after high-profile cases like that of Alfie Dingley. However, access is tightly regulated and prescriptions are typically issued by specialist doctors. Frontier Botanics operates fully within UK and international legal frameworks to ensure compliance at every stage of production and distribution.
Lesotho was the first African nation to legalise medical cannabis cultivation and export, offering a stable regulatory environment, favourable climate, and cost-efficient production conditions. This allows Frontier Botanics to produce high-quality, pharmaceutical-grade cannabis at scale while maintaining competitive pricing for international markets.
Frontier Botanics focuses on vertically integrated operations—from cultivation in Lesotho to distribution in the UK—ensuring full control over quality, compliance, and supply chain efficiency. The company combines pharmaceutical standards with scalable infrastructure, positioning itself to meet growing demand in regulated global markets.
Frontier Botanics is currently raising capital to expand cultivation capacity, enhance processing facilities, and secure additional distribution partnerships. The funding round is designed to accelerate growth, increase production output, and strengthen the company’s position within the rapidly expanding global medical cannabis market.
The global medical cannabis market is projected to grow significantly over the coming decade, driven by increasing legalisation, patient demand, and clinical research. Countries across Europe—including the UK—are gradually expanding access, creating a strong long-term growth opportunity for early-stage, compliant operators like Frontier Botanics.
Whether you’re an investor, partner, or simply want to learn more about Frontier Botanics, our team is here to help. We welcome enquiries regarding our operations, investment opportunities, and strategic partnerships.

First Floor 690 Great West Road, Osterley Village, Isleworth, England, TW7 4PU
New Frontier Holdings Ltd
First Floor 690 Great West Road, Osterley Village, Isleworth, England TW7 4PU
Company No. 12111072
England & Wales
Frontier Botanics Lesotho (Proprietary) Limited, Morena Khoase Kolobe, Mohalalitoe Road Maseru, Kingdom of Lesotho
© 2026 New Frontier Holdings Ltd.